DexCom, Inc. (LON:0A4M)

Market Cap	19.26B
Revenue (ttm)	3.36B
Net Income (ttm)	536.16M
Shares Out	n/a
EPS (ttm)	1.34
PE Ratio	35.93
Forward PE	27.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	5,373
Open	62.79
Previous Close	59.52
Day's Range	62.79 - 62.79
52-Week Range	56.00 - 90.77
Beta	n/a
RSI	39.55
Earnings Date	Feb 13, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4M

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD